Back
Santen Pharmaceutical Co., Ltd. Vs. Becton, Dickinson & Co. Industry Stock Comparison
Sell
45
SNPHF
Santen Pharmaceutical Co., Ltd.
Last Price:
$10.99
Seasonality Move:
2.86%
Buy
51
BDX
Becton, Dickinson & Co.
Last Price:
$154.51
Seasonality Move:
1.78%
Sell
45
Santen Pharmaceutical Co., Ltd. (SNPHF)
is a Sell
Is Santen Pharmaceutical Co., Ltd. a Buy, Sell or Hold?
-
The current Santen Pharmaceutical Co., Ltd. [SNPHF] share price is $10.99. The Score for SNPHF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
SNPHF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Becton, Dickinson & Co. (BDX)
is a Buy
Is Becton, Dickinson & Co. a Buy, Sell or Hold?
-
The current Becton, Dickinson & Co. [BDX] share price is $154.51. The Score for BDX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
BDX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SNPHF Stock Price Chart
What is Santen Pharmaceutical Co., Ltd.'s stock price today?
-
The Santen Pharmaceutical Co., Ltd. share price today is $10.99The current trend is relatively stagnant and SNPHF is experiencing slight buying pressure.
BDX Stock Price Chart
What is Becton, Dickinson & Co.'s stock price today?
-
The Becton, Dickinson & Co. share price today is $154.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDX is experiencing slight selling pressure.
SNPHF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 99.76 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.67 - 11.13) | Buy |
| Bollinger Bands (100): | (9.27 - 10.33) | Buy |
BDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.53 | Sell |
| Relative Strength Index (14 RSI): | 36.27 | Sell |
| Chaikin Money Flow: | -985081 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (154.75 - 168.69) | Sell |
| Bollinger Bands (100): | (150.31 - 169.55) | Sell |
SNPHF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.99 | Sell |
| 20-day SMA: | 10.62 | Buy |
| 50-day SMA: | 9.95 | Buy |
| 200-day SMA: | 10.53 | Buy |
| 8-day EMA: | 10.96 | Buy |
| 20-day EMA: | 10.66 | Buy |
| 50-day EMA: | 10.21 | Buy |
| 200-day EMA: | 10.28 | Buy |
BDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 156.11 | Sell |
| 20-day SMA: | 158.72 | Sell |
| 50-day SMA: | 165.86 | Sell |
| 200-day SMA: | 152.46 | Buy |
| 8-day EMA: | 156.19 | Sell |
| 20-day EMA: | 159.46 | Sell |
| 50-day EMA: | 162.24 | Sell |
| 200-day EMA: | 158.44 | Sell |
Santen Pharmaceutical Co., Ltd. Earnings Growth & SNPHF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Becton, Dickinson & Co. Earnings Growth & BDX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.24 per share, a decrease this year of $1.92 per share, and an increase next year of $1.06 per share.
Santen Pharmaceutical Co., Ltd. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Becton, Dickinson & Co. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||